The aussie remained gently offered last week and this can actually be considered a sign of resilience of the currency, in the view of economists at ING. Looking ahead, the worrying covid situation in Australia is set to weigh on the AUD/USD pair.
Hard to see any material improvement in the aussie
“Along with a worsening sentiment in Asia and in China in particular (to which AUD has a high beta), Australia is facing its worst covid crisis so far, with major cities having to enter or extend lockdowns.”
“The fact that only 16% of the population in Australia has been fully vaccinated argues against a quick resolution to the current epidemic crisis.”
“Iron ore prices have continued to drop and have now reached the $130/MT level, close to 5-month lows.”
“Along with the RBA minutes on Tuesday, we will see July jobs data on Thursday. Any signs of a less dovish RBA in the minutes or another marginal drop in unemployment may give little help to AUD as they would both be seen as outdated considering the material worsening of the COVID-19 situation in Australia in August.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.